KAIROS PHARMA, LTD. (KAPA) Net income 2023–2025
KAIROS PHARMA, LTD. (KAPA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$5.4MFY2025 · since FY2023: -$1.8M → -$5.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.4M | -109.3% |
| FY2024 | -$2.6M | -43.7% |
| FY2023 | -$1.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KAPA financial trends
KAPA RevenueKAPA Net marginKAPA Gross profitKAPA Gross marginKAPA Operating incomeKAPA Operating marginKAPA Operating cash flowKAPA Free cash flowKAPA Capital expendituresKAPA Return on equityKAPA Stock buybacksKAPA Dividends paidKAPA Total assetsKAPA Total liabilitiesKAPA Shareholders’ equityKAPA overview →